Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Negre, Olivier (Author) , Bartholomä, Cynthia C. (Author) , Deichmann, Annette (Author) , Fronza, Raffaele (Author) , Schmidt, Manfred (Author) , Kalle, Christof von (Author)
Format:	Article (Journal)
Language:	English
Published:	2015
In:	Current gene therapy Year: 2015, Volume: 15, Issue: 1, Pages: 64-81
ISSN:	1875-5631
DOI:	10.2174/1566523214666141127095336
Online Access:	Verlag, Volltext: http://dx.doi.org/ 10.2174/1566523214666141127095336
Author Notes:	Olivier Negre, Cynthia Bartholomä, Yves Beuzard, Marina Cavazzana, Lauryn Christiansen, Céline Courne, Annette Deichmann, Maria Denaro, Edouard de Dreuzy, Mitchell Finer, Raffaele Fronza, Béatrix Gillet-Legrand, Christophe Joubert, Robert Kutner, Philippe Leboulch, Leïla Maouche, Anaïs Paulard, Francis J. Pierciey Jr., Michael Rothe, Byoung Ryu, Manfred Schmidt, Christof von Kalle, Emmanuel Payen, and Gabor Veres

Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease by Negre, Olivier (Author) , Bartholomä, Cynthia C. (Author) , Deichmann, Annette (Author) , Fronza, Raffaele (Author) , Schmidt, Manfred (Author) , Kalle, Christof von (Author) ,

in: Current gene therapy, 15 (2015), 1, Seite 64-81

Article (Journal) Online Resource